BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.15
+0.45 (0.44%)
At close: Nov 28, 2025, 4:00 PM EST
102.90
-0.25 (-0.24%)
After-hours: Nov 28, 2025, 4:15 PM EST
BioNTech SE Revenue
BioNTech SE had revenue of 1.52B EUR in the quarter ending September 30, 2025, with 22.02% growth. This brings the company's revenue in the last twelve months to 3.15B, up 3.70% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.
Revenue (ttm)
3.15B EUR
Revenue Growth
+3.70%
P/S Ratio
6.69
Revenue / Employee
465,520 EUR
Employees
6,772
Market Cap
24.80B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
| Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BNTX News
- 2 days ago - BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration - GlobeNewsWire
- 10 days ago - BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript - Seeking Alpha
- 14 days ago - Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up - Reuters
- 15 days ago - Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run - Benzinga
- 15 days ago - BioNTech says collaboration with Pfizer remains unchanged - Reuters
- 25 days ago - BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold - Seeking Alpha
- 25 days ago - BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership - Benzinga